Physician profile
Bryant Tran
NPI 1073974044
$3,374.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,047 · 2020: $963 · 2021: $1,312 · 2022: $35.90 · 2023: $16.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $610.43 | 2020-2021 | |
| Lilly USA, LLC | $308.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $296.13 | 2019-2020 | |
| Glaxosmithkline, LLC. | $278.64 | 2019-2022 | |
| Abbvie INC. | $274.62 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.62 | 2020-2021 | |
| Pfizer INC. | $196.20 | 2019 | |
| Amgen INC. | $187.60 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $147.37 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $142.23 | 2021 | |
| Amarin Pharma, INC. | $125.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $124.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $119.37 | 2019-2020 | |
| Optinose US, INC. | $114.58 | 2021 | |
| Alkermes, INC. | $47.72 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $39.04 | 2019 | |
| Merck Sharp & Dohme LLC | $30.04 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $16.46 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.39 | 2023 | Dupixent |
| Allergan, INC. | $15.06 | 2020 | |
| Ibsa Pharma INC. | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryant Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.